Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool
Asian Journal of Urology · 2026-11
DOI: 10.1016/j.ajur.2026.02.005 ↗Kurz gefasst
Leitlinie in der Zeitschrift Asian Journal of Urology, 2026-11. Verfasst von Wen Tan und 7 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tan, W., Zhan, H., Yang, Z., Wang, Y., Lin, Y., Yang, T., Zhao, L., & Sun, D. (2026). Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool. Asian Journal of Urology. https://doi.org/10.1016/j.ajur.2026.02.005
Vancouver
Tan W, Zhan H, Yang Z, Wang Y, Lin Y, Yang T, et al. Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool. Asian Journal of Urology. 2026. doi:10.1016/j.ajur.2026.02.005
BibTeX
@article{Tan2026,
author = {Tan, Wen and Zhan, Hui and Yang, Zihan and Wang, Yuanshan and Lin, Yueying and Yang, Ting and Zhao, Ling and Sun, Dali},
title = {Consensus and controversy among guidelines for the diagnosis and treatment of renal cell carcinoma: A quality assessment of guidelines based on the AGREE II tool},
journal = {Asian Journal of Urology},
year = {2026},
doi = {10.1016/j.ajur.2026.02.005}
}
EUVIMED